PEOPLE - Changes at St Jude Medical:
This article was originally published in Clinica
Executive Summary
St Jude Medical has announced the creation of two new divisions by the end of the year: cardiology and atrial fibrillation. The cardiology division will be led by Paul Buckman, who has previously served for Boston Scientific. The atrial fibrillation division will be led by Jane Song, who steps down as president of the cardiac surgery division, and was previously senior vice-president of operations for the cardiac rhythm management unit. The St Paul, Minnesota-based firm has also named Ms Song's successor, George Fazio, president of St Jude's Europe division, who joined the company in 1992. The vice-president for northern Europe and Africa, Denis Gestin, will succeed Mr Fazio. Mr Gestin also previously managed the firm's subsidiary in France.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.